Meta Platforms is the IBD Stock of the Day for Monday. Shares of the Facebook parent company have formed a flat base pattern after bouncing back last week from a slight earnings letdown. Please watch ...

Bristol Myers Squibb stock rocketed Monday after AbbVie's experimental schizophrenia treatment failed in a pair of midstage studies.

Vertiv stock shares have risen 175% as of November 11. Last month, the data center hardware and services provider exceeded ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

It’s the first time that the IBD 50 would be an investable product. But early investors into the fund didn’t get the kind of performance they were hoping for. From the fund’s launch in April ...

Here is a breakdown of the information Ventyx Biosciences, Inc. presented to its investors. Ventyx Biosciences ... The company also reported progress in its NLRP3 and IBD portfolios, emphasizing ...

Bond yields rose early Tuesday as the market returned after the Veterans Day holiday and investors sold Treasurys in anticipation ... Christopher Waller speaks at Clearing House conference. -- 10:10 a ...

Google is making AI pay off in the form of faster growth and higher profitability. If the company keeps beating expectations, ...

Living with IBD and having symptoms of Inflammatory Bowel Disease is hard in and of itself. It tends to create a lot of stress for people. When I'm looking at someone who's really, really starting ...

LLY’s slashed revenue and earnings guidance for 2024 were a surprise, especially given substantial raises to its outlook ...

VIENNA — Researchers have determined a bidirectional relationship between inflammatory bowel disease (IBD) and type 1 diabetes (T1D), using both a cohort and case-control approach to analysis.

Thetis Pharmaceuticals Announces Positive Initial Results From a Phase 1a Study of TP-317, a BLT1 Agonist, in Healthy ...